10x Genomics, Inc. is a life sciences technology company that develops tools for analyzing biological systems at high resolution. Its platforms are used by academic and government research institutions, pharmaceutical and biotechnology companies, and other organizations studying genomics, cell biology, immunology, neuroscience, and disease mechanisms.
The company’s product portfolio includes the Chromium platform for single-cell and other multiomics analyses, the Visium platform for spatial analysis of tissue, and the Xenium platform for high-plex in situ analysis of gene expression. These systems combine specialized instruments, consumables, assay kits, and software designed to help researchers examine genetic and molecular information while preserving details about individual cells and their locations within tissue.
Founded in 2012, 10x Genomics is headquartered in Pleasanton, California, and serves customers internationally through direct sales and distribution channels. The company was co-founded by Serge Saxonov, who has served as its chief executive officer, and has built its business around expanding the use of single-cell and spatial biology technologies in research and drug discovery.
AI Generated. May Contain Errors.
Free TXG Stock Alerts